Adderall vs. Vyvanse:
same family, different personalities

If you've been diagnosed with ADHD, you've probably heard of both Adderall and Vyvanse. They're the two most well known stimulant medications for attention deficit hyperactivity disorder, and they're both amphetamine based. But they're not the same drug, and the differences between them matter more than most people realize.

The Family Resemblance

Both Adderall and Vyvanse belong to the amphetamine family. They work by increasing dopamine and norepinephrine in the brain, two neurotransmitters that play a central role in attention, motivation, and executive function.

Adderall (mixed amphetamine salts) contains a 3:1 ratio of d-amphetamine to l-amphetamine. It comes in both an immediate release form (lasting 4 to 6 hours) and an extended release form, Adderall XR (lasting about 12 hours).

Vyvanse (lisdexamfetamine) is a prodrug, meaning it's inactive when you swallow it. It only becomes active after enzymes in your blood cleave off a lysine amino acid, converting it into d-amphetamine. This built in activation step is what makes Vyvanse unique.

How They Feel Different

Because Vyvanse requires enzymatic conversion before it starts working, the onset is more gradual, roughly one hour later than an equivalent dose of d-amphetamine. The therapeutic effect of Vyvanse extends to at least 13 to 14 hours, which is longer than any other long acting amphetamine formulation.

Many patients describe Vyvanse as "smoother." A crossover study in adults with ADHD found that twice daily dexamphetamine produced more pronounced fluctuations in subjective effects compared to once daily lisdexamfetamine, which had a more consistent pharmacokinetic profile throughout the day. This smoother curve may translate to fewer peaks and valleys in focus and mood.

Adderall XR, while also extended release, uses a bead delivery system that releases medication in two pulses. Some patients prefer this because it can provide a stronger initial effect in the morning. Others find the two pulse system creates a noticeable dip and second wave.

Effectiveness: Are They Equally Powerful?

In a Cochrane review of amphetamines for adult ADHD, both lisdexamfetamine and mixed amphetamine salts significantly reduced ADHD symptoms compared to placebo. Lisdexamfetamine showed a slightly larger effect size on clinician rated symptoms (SMD of negative 1.06) compared to mixed amphetamine salts (SMD of negative 0.80), though direct head to head comparisons are limited.

A large network meta-analysis found that amphetamines as a class were the most effective pharmacotherapy for ADHD in adults, outperforming methylphenidate, atomoxetine, and bupropion in head to head comparisons.

The side effect profiles are similar for both: appetite suppression, insomnia, dry mouth, and increased heart rate are the most common. Neither medication showed a difference in overall adverse event rates in pooled analyses.

The Abuse Question

This is where the conversation gets important. Both Adderall and Vyvanse are Schedule II controlled substances. But their abuse profiles are not identical.

Vyvanse was specifically designed to have a lower potential for misuse. Because it requires enzymatic conversion, it cannot be "activated" faster by crushing, snorting, or injecting it. Poison control data shows that abuse and misuse reports were significantly lower for lisdexamfetamine (13.5%) compared to Adderall XR (23.0%) and immediate release Adderall (32.5%).

However, the picture is more nuanced than marketing might suggest. When taken orally at equivalent doses, pharmacokinetic studies have shown that lisdexamfetamine and d-amphetamine produce similar peak concentrations and similar peak ratings of drug liking, euphoria, and stimulation. The clinical relevance of the prodrug mechanism for reducing oral abuse has not been definitively established.

In practical terms: Vyvanse does appear harder to misuse through non-oral routes, which matters in households with teens or in situations where diversion is a concern. But for someone taking their medication as prescribed by mouth, the subjective experience is quite similar.

Cost and Access

This is often the deciding factor. Adderall has been available as a generic for years, making it significantly less expensive. Vyvanse lost patent exclusivity more recently, and generic lisdexamfetamine is now available, though pricing varies.

Insurance coverage, copays, and pharmacy availability can all influence which medication is more practical. A medication that works perfectly but sits uncollected at the pharmacy because of cost isn't helping anyone.

Which One Might Be Right for You?

Vyvanse may be preferred when a longer, smoother duration of action is desired, when there is concern about misuse or diversion (especially in households with adolescents), when once daily dosing with minimal peaks and valleys is a priority, or when immediate release Adderall has caused uncomfortable "wearing off" effects.

Adderall may be preferred when cost is a significant factor, when a shorter acting option is needed for flexible scheduling (immediate release), when a patient has responded well to it historically, or when the two pulse release profile of Adderall XR is a better fit for a patient's daily schedule.

The Bottom Line

Adderall and Vyvanse are close relatives, not clones. They share the same active ingredient family but deliver it to the brain in meaningfully different ways. Neither is universally "better." The right choice depends on how your body responds, what your daily schedule looks like, what your budget allows, and what concerns matter most to you. That's a conversation worth having with your provider.